| MeSH term | MeSH ID | Detail |
|---|---|---|
| Starvation | D013217 | 47 associated lipids |
| Ventricular Dysfunction, Left | D018487 | 33 associated lipids |
| Heart Failure, Systolic | D054143 | 3 associated lipids |
Total
3
O-octanoylcarnitine
O-octanoylcarnitine is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 212 references associated with O-octanoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for O-octanoylcarnitine
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with O-octanoylcarnitine
NCBI Entrez Crosslinks
All references with O-octanoylcarnitine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rhead WJ | Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective. | 2006 Apr-Jun | J. Inherit. Metab. Dis. | pmid:16763904 |
| de Assis DR et al. | Na+, K+ ATPase activity is markedly reduced by cis-4-decenoic acid in synaptic plasma membranes from cerebral cortex of rats. | 2006 | Exp. Neurol. | pmid:16203000 |
| Baumgartner C and Baumgartner D | Biomarker discovery, disease classification, and similarity query processing on high-throughput MS/MS data of inborn errors of metabolism. | 2006 | J Biomol Screen | pmid:16314408 |
| Ensenauer R et al. | Genotypic differences of MCAD deficiency in the Asian population: novel genotype and clinical symptoms preceding newborn screening notification. | 2005 May-Jun | Genet. Med. | pmid:15915086 |
| Jogl G et al. | Crystal structure of mouse carnitine octanoyltransferase and molecular determinants of substrate selectivity. | 2005 | J. Biol. Chem. | pmid:15492013 |
| Lehotay DC et al. | Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype? | 2004 | J. Inherit. Metab. Dis. | pmid:14970748 |
| Pourfarzam M et al. | Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. | 2001 | Lancet | pmid:11589939 |
| Carpenter K et al. | Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. | 2001 | Arch. Dis. Child. Fetal Neonatal Ed. | pmid:11517203 |
| Chace DH et al. | Errors caused by the use of D,L-octanoylcarnitine for blood-spot calibrators. | 2001 | Clin. Chem. | pmid:11274033 |
| Toleikis A et al. | Relevance of fatty acid oxidation in regulation of the outer mitochondrial membrane permeability for ADP. | 2001 | FEBS Lett. | pmid:11741597 |